This article is more than 5 years old. Information may no longer be current.
Yale Cancer Center names neuro-oncology chief
Click Here to Manage Email Alerts
Antonio Omuro, MD, has been named chief of neuro-oncology at Yale Cancer Center.
Omuro also will serve as a leader of the brain tumor program at Smilow Cancer Hospital at Yale New Haven.
The appointments will take effect Dec. 1.
“I’m really excited to join Yale Cancer Center and Smilow Cancer Hospital,” Omuro said in a press release. “I am eager to work with our great scientists and clinicians to develop better treatments for brain tumors and, together, make a difference in the lives of our patients.”
Omuro most recently served as chief of the neuro-oncology division and head of the brain tumor program at University of Miami. He previously held several positions as a faculty member and researcher at Memorial Sloan Kettering Cancer Center, and also worked as a clinician and researcher at Pitie-Salpetriere Hospital at Sorbonne Universities in Paris.
“We are so fortunate to have recruited Dr. Omuro to lead our efforts in brain tumors and other nervous system cancers at our center,” Charles S. Fuchs, MD, MPH, director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital, said in the release. “Yale Cancer Center and Smilow Cancer Hospital are committed to meaningfully improving the outcome of patients with these cancers. Dr. Omuro will do great things at Yale and Smilow, and he will be transformational for our neuro-oncology program.”